Exelixis (EXEL) 30-day volatility at 106 compared to 60 from a month ago
Get access to the best calls on Wall Street with StreetInsider.com's Ratings Insider Elite. Get your Free Trial here.
Exelixis (NASDAQ: EXEL) is recently down 17% on cabozantinib and Opdivo data concerns. 30-day call option implied volatility of 106 compares to volatility of 60 from a month ago.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Stocks with call price movement; LC TWTR
- Baker Hughes (BHI) October weekly 52 straddle priced for movement of 3.8% into Q3
- AT&T (T) volatility up into buyout of Time Warner (TWX)
Create E-mail Alert Related CategoriesOptions, Trader Talk
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!